Evaluation of Hemoadsorption Capacity of the CytoSorb Adsorber for Toxic Doses of Diclofenac and Meloxicam in Porcine Plasma
Journal of Clinical Apheresis · 2026-06 · 41 (3)
DOI: 10.1002/jca.70130 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Apheresis, online erschienen am 01.05.2026. Verfasst von Bettina Giani und 3 weiteren Autor:innen. Beteiligte Einrichtung: LMU Small Animal Clinic, Center for Clinical Veterinary Medicine, Faculty of Veterinary Medicine, Ludwig-Maximilians-Universität München, Munich, Ger…. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Non-Steroidal, Diclofenac, Extracorporeal Circulation, Meloxicam. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The objective of this in vitro experimental was to determine the utility of hemoadsorption (HA) using the CytoSorb adsorber to remove meloxicam and diclofenac from porcine plasma. For this purpose 12 1‐L aliquots of porcine plasma, 6 units were spiked with 293 μg/mL (262–320 μg/mL) diclofenac and 6 with 42.8 μg/mL (41.4–44.7 μg/mL) meloxicam, respectively. Each unit was processed in a circular setup with the CytoSorb adsorber using the PuriFi HA platform until a recirculated volume of 20 L was reached. Pre‐ and post‐adsorber samples were obtained at seven time points. Percentage reduction, clearance, and change from baseline were calculated. Drug concentrations were compared using Friedmann test with post hoc Dunn's multiple comparison test and Wilcoxon matched pairs rank sum test. p < 0.05 were considered significant. Diclofenac was reduced by a median of 242 mg (204–262 mg; 82.1%; 77.0%–83.6%). Total clearance was 40.5 mL/min (33.2–46.2 mL/min). Clearance at a plasma flow of 100 mL/min decreased from 39.9 mL/min (25.3–46.6 mL/min) at 0.2 L to 6.4 mL/min (−3.8 to 14.8 mL/min) at 20 L. Median reduction of meloxicam was 40.4 mg (38.6–42.2 mg; 94.4%; 93.2%–94.6%); total clearance was 94.38 mL/min (93.2–94.6 mL/min). Clearance at a plasma flow of 100 mL/min decreased from 65.3 mL/min (56.7–71.7 mL/min) at 0.2 L to 3.6 mL/min (−13.0 to 4.2 mL/min) at 20 L. HA using the CytoSorb adsorber successfully removed meloxicam and diclofenac from porcine plasma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- LMU Small Animal Clinic, Center for Clinical Veterinary Medicine, Faculty of Veterinary Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.
ORCID-Profile: Bettina Giani, René Dörfelt
Zitieren
APA
Giani, B., Dörfelt, R., Hartmann, K., & Sänger, F. (2026). Evaluation of Hemoadsorption Capacity of the CytoSorb Adsorber for Toxic Doses of Diclofenac and Meloxicam in Porcine Plasma. Journal of Clinical Apheresis, 41(3). https://doi.org/10.1002/jca.70130
Vancouver
Giani B, Dörfelt R, Hartmann K, Sänger F. Evaluation of Hemoadsorption Capacity of the CytoSorb Adsorber for Toxic Doses of Diclofenac and Meloxicam in Porcine Plasma. Journal of Clinical Apheresis. 2026;41(3). doi:10.1002/jca.70130
BibTeX
@article{Giani2026,
author = {Giani, Bettina and Dörfelt, René and Hartmann, Katrin and Sänger, Florian},
title = {Evaluation of Hemoadsorption Capacity of the CytoSorb Adsorber for Toxic Doses of Diclofenac and Meloxicam in Porcine Plasma},
journal = {Journal of Clinical Apheresis},
year = {2026},
volume = {41},
number = {3},
doi = {10.1002/jca.70130}
}
EUVIMED